BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 10656819)

  • 1. Display of active subtilisin 309 on phage: analysis of parameters influencing the selection of subtilisin variants with changed substrate specificity from libraries using phosphonylating inhibitors.
    Legendre D; Laraki N; Gräslund T; Bjørnvad ME; Bouchet M; Nygren PA; Borchert TV; Fastrez J
    J Mol Biol; 2000 Feb; 296(1):87-102. PubMed ID: 10656819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering a substrate-specific cold-adapted subtilisin.
    Tindbaek N; Svendsen A; Oestergaard PR; Draborg H
    Protein Eng Des Sel; 2004 Feb; 17(2):149-56. PubMed ID: 15047911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of hydrophobic S4-P4 interactions in subtilisin 309 from Bacillus lentus.
    Bech LM; Sørensen SB; Breddam K
    Biochemistry; 1993 Mar; 32(11):2845-52. PubMed ID: 8457550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of Streptomyces griseus protease B mutants with desired alterations in primary specificity using a library screening strategy.
    Sidhu SS; Borgford TJ
    J Mol Biol; 1996 Mar; 257(2):233-45. PubMed ID: 8609620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Furilisin: a variant of subtilisin BPN' engineered for cleaving tribasic substrates.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1996 Oct; 35(42):13579-85. PubMed ID: 8885837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do enzymes change the nature of transition states? Mapping the transition state for general acid-base catalysis of a serine protease.
    Bott RR; Chan G; Domingo B; Ganshaw G; Hsia CY; Knapp M; Murray CJ
    Biochemistry; 2003 Sep; 42(36):10545-53. PubMed ID: 12962477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational replacements of the amino acid residues forming the hydrophobic S4 binding pocket of subtilisin 309 from Bacillus lentus.
    Sørensen SB; Bech LM; Meldal M; Breddam K
    Biochemistry; 1993 Sep; 32(35):8994-9. PubMed ID: 8369272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of amino acid side-chains to S1 cavities of serine proteinases.
    Lu W; Apostol I; Qasim MA; Warne N; Wynn R; Zhang WL; Anderson S; Chiang YW; Ogin E; Rothberg I; Ryan K; Laskowski M
    J Mol Biol; 1997 Feb; 266(2):441-61. PubMed ID: 9047374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemically modified "polar patch" mutants of subtilisin in peptide synthesis with remarkably broad substrate acceptance: designing combinatorial biocatalysts.
    Matsumoto K; Davis BG; Jones JB
    Chemistry; 2002 Sep; 8(18):4129-37. PubMed ID: 12298003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered flexibility in the substrate-binding site of related native and engineered high-alkaline Bacillus subtilisins.
    Mulder FA; Schipper D; Bott R; Boelens R
    J Mol Biol; 1999 Sep; 292(1):111-23. PubMed ID: 10493861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel peptide substrate of HSV-1 protease using substrate phage display.
    O'Boyle DR; Pokornowski KA; McCann PJ; Weinheimer SP
    Virology; 1997 Sep; 236(2):338-47. PubMed ID: 9325241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and biochemical characterization of a novel glutamyl endopeptidase secreted by a clinical isolate of Staphylococcus aureus.
    Park JW; Park JE; Park JK; Lee JS
    Int J Mol Med; 2011 May; 27(5):637-45. PubMed ID: 21347511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease.
    Tong L; Qian C; Massariol MJ; Déziel R; Yoakim C; Lagacé L
    Nat Struct Biol; 1998 Sep; 5(9):819-26. PubMed ID: 9731777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolation of glutamylendopeptidase precursor from B. licheniformis and its processing in vitro].
    Serkina AV; Bushueva AM; Chestukhina GG; Gumpert J; Hoischen C; Kujau M; Shevelev AB
    Vopr Med Khim; 2001; 47(1):111-22. PubMed ID: 11385993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering a novel specificity in subtilisin BPN'.
    Rheinnecker M; Baker G; Eder J; Fersht AR
    Biochemistry; 1993 Feb; 32(5):1199-203. PubMed ID: 8448130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two novel fibrinolytic enzymes from Bacillus subtilis QK02.
    Ko JH; Yan JP; Zhu L; Qi YP
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Jan; 137(1):65-74. PubMed ID: 14984705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage display as a tool for the directed evolution of enzymes.
    Fernandez-Gacio A; Uguen M; Fastrez J
    Trends Biotechnol; 2003 Sep; 21(9):408-14. PubMed ID: 12948674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of catalytically active biotin ligase and trypsin mutants by phage display.
    Heinis C; Huber A; Demartis S; Bertschinger J; Melkko S; Lozzi L; Neri P; Neri D
    Protein Eng; 2001 Dec; 14(12):1043-52. PubMed ID: 11809935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and molecular characterization of a detergent-stable serine alkaline protease from Bacillus pumilus CBS with high catalytic efficiency.
    Jaouadi B; Ellouz-Chaabouni S; Rhimi M; Bejar S
    Biochimie; 2008 Sep; 90(9):1291-305. PubMed ID: 18397761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
    Jani M; Tordai H; Trexler M; Bányai L; Patthy L
    Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.